Rochester, NY, United States
Rochester, NY, United States

Time filter

Source Type

News Article | December 6, 2016
Site: www.prweb.com

Career Step, an online provider of career-focused education and professional training, has enhanced its Pharmacy Technician course offering to meet American Society of Health-System Pharmacists (ASHP) requirements. Accordingly, the program has been submitted for ASHP accreditation. In conjunction with the updates, Career Step has renewed its partnership with Paradigm, whose content is aligned with the ASHP Model 4 curriculum. These changes will improve the educational experience and allow students to excel in their chosen career as a pharmacy technician. “We have increased our hours from 285 to 600 in order to expand our program and enrich the preparation of our students,” said Jerolyn Robertson, Career Step Vice President of Academics. “We now include more simulations and have added 200 hours of required externship, which means our students will be well prepared to move into their career upon graduation.” The Career Step Pharmacy Technician training program covers pharmacology, pharmacy law, prescriptions, nonsterile compounding and additional material, to prepare students for the field. The course incorporates feedback from employers and prepares students to take the Pharmacy Technician Certification Board (PTCB) Exam upon graduation. The opportunity to participate in a local externship though Walgreens or CVS Pharmacy is also an option in most areas across the U.S., making it easier for students to fulfill their required externship. “Student success is our highest priority at Career Step, and providing excellent curriculum is a vital part of helping our students develop the skills they need to succeed,” said Laurie McBrierty, Career Step Vice President of Product Management. “These updates ensure that we keep pace with industry trends, standards and accreditations.” For more information on Career Step’s Pharmacy Technician program, visit CareerStep.com/pharmacy-technician-careers or call 1-800-246-7837. About Career Step Career Step is an online provider of career-focused education and professional training. The company has trained over 100,000 students for new careers as well as more than 100,000 healthcare professionals through its various continuing education courses. More than 150 colleges and universities nationwide have partnered with Career Step, and the company provides training for several of the largest and most respected healthcare employers in the nation. Career Step is committed to helping students and practicing healthcare professionals alike gain the skills they need to be successful in the workplace—improving lives, advancing careers and driving business results through education. More information can be found at http://www.careerstep.com or 1-800-246-7836.


News Article | December 7, 2016
Site: www.PR.com

Career Step has enhanced its Pharmacy Technician program offerings to include an additional 315 hours of curriculum in order to meet ASHP requirements. Lehi, UT, December 07, 2016 --( “We have increased our hours from 285 to 600 in order to expand our program and enrich the preparation of our students,” said Jerolyn Robertson, Career Step Vice President of Academics. “We now include more simulations and have added 200 hours of required externship, which means our students will be well prepared to move into their career upon graduation.” The Career Step Pharmacy Technician training program covers pharmacology, pharmacy law, prescriptions, nonsterile compounding and additional material, to prepare students for the field. The course incorporates feedback from employers and prepares students to take the Pharmacy Technician Certification Board (PTCB) Exam upon graduation. The opportunity to participate in a local externship though Walgreens or CVS Pharmacy is also an option in most areas across the U.S., making it easier for students to fulfill their required externship. “Student success is our highest priority at Career Step, and providing excellent curriculum is a vital part of helping our students develop the skills they need to succeed,” said Laurie McBrierty, Career Step Vice President of Product Management. “These updates ensure that we keep pace with industry trends, standards and accreditations.” For more information on Career Step’s Pharmacy Technician program, visit CareerStep.com/pharmacy-technician-careers or call 1-800-246-7837. About Career Step Career Step is an online provider of career-focused education and professional training. The company has trained over 100,000 students for new careers as well as more than 100,000 healthcare professionals through its various continuing education courses. More than 150 colleges and universities nationwide have partnered with Career Step, and the company provides training for several of the largest and most respected healthcare employers in the nation. Career Step is committed to helping students and practicing healthcare professionals alike gain the skills they need to be successful in the workplace—improving lives, advancing careers and driving business results through education. More information can be found at www.careerstep.com or 1-800-246-7836. Lehi, UT, December 07, 2016 --( PR.com )-- Career Step, an online provider of career-focused education and professional training, has enhanced its Pharmacy Technician course offering to meet American Society of Health-System Pharmacists (ASHP) requirements. Accordingly, the program has been submitted for ASHP accreditation. In conjunction with the updates, Career Step has renewed its partnership with Paradigm, whose content is aligned with the ASHP Model 4 curriculum. These changes will improve the educational experience and allow students to excel in their chosen career as a pharmacy technician.“We have increased our hours from 285 to 600 in order to expand our program and enrich the preparation of our students,” said Jerolyn Robertson, Career Step Vice President of Academics. “We now include more simulations and have added 200 hours of required externship, which means our students will be well prepared to move into their career upon graduation.”The Career Step Pharmacy Technician training program covers pharmacology, pharmacy law, prescriptions, nonsterile compounding and additional material, to prepare students for the field. The course incorporates feedback from employers and prepares students to take the Pharmacy Technician Certification Board (PTCB) Exam upon graduation. The opportunity to participate in a local externship though Walgreens or CVS Pharmacy is also an option in most areas across the U.S., making it easier for students to fulfill their required externship.“Student success is our highest priority at Career Step, and providing excellent curriculum is a vital part of helping our students develop the skills they need to succeed,” said Laurie McBrierty, Career Step Vice President of Product Management. “These updates ensure that we keep pace with industry trends, standards and accreditations.”For more information on Career Step’s Pharmacy Technician program, visit CareerStep.com/pharmacy-technician-careers or call 1-800-246-7837.About Career StepCareer Step is an online provider of career-focused education and professional training. The company has trained over 100,000 students for new careers as well as more than 100,000 healthcare professionals through its various continuing education courses. More than 150 colleges and universities nationwide have partnered with Career Step, and the company provides training for several of the largest and most respected healthcare employers in the nation. Career Step is committed to helping students and practicing healthcare professionals alike gain the skills they need to be successful in the workplace—improving lives, advancing careers and driving business results through education. More information can be found at www.careerstep.com or 1-800-246-7836. Click here to view the list of recent Press Releases from Career Step


— Pharmacy Retailing is drugs sold in the retail and bought on the internet, not in the hospital. This report focuses on the Pharmacy Retailing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. For more information or any query mail at sales@wiseguyreports.com Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Applications, can be divided into OTC Rx Complete Report Details @ https://www.wiseguyreports.com/reports/931952-global-pharmacy-retailing-market-forecast-to-2022 There are 15 Chapters to deeply display the global Pharmacy Retailing market. Chapter 2, to analyze the top manufacturers of Pharmacy Retailing, with sales, revenue, and price of Pharmacy Retailing, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Pharmacy Retailing, for each region, from 2012 to 2017; 2 Manufacturers Profiles 2.1 CVS 2.1.1 Business Overview 2.1.2 Pharmacy Retailing Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 CVS Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Walgreen 2.2.1 Business Overview 2.2.2 Pharmacy Retailing Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Walgreen Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Rite Aid 2.3.1 Business Overview 2.3.2 Pharmacy Retailing Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Rite Aid Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Loblaw 2.4.1 Business Overview 2.4.2 Pharmacy Retailing Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Loblaw Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Diplomat 2.5.1 Business Overview 2.5.2 Pharmacy Retailing Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Diplomat Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Ahold? 2.6.1 Business Overview 2.6.2 Pharmacy Retailing Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Ahold? Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 AinPharmaciez 2.7.1 Business Overview 2.7.2 Pharmacy Retailing Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 AinPharmaciez Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Guoda Drugstore 2.8.1 Business Overview 2.8.2 Pharmacy Retailing Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Guoda Drugstore Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Yixintang 2.9.1 Business Overview 2.9.2 Pharmacy Retailing Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 Yixintang Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 Albertsons 2.10.1 Business Overview 2.10.2 Pharmacy Retailing Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 Albertsons Pharmacy Retailing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Pharmacy Retailing Market Competition, by Manufacturer 3.1 Global Pharmacy Retailing Sales and Market Share by Manufacturer 3.2 Global Pharmacy Retailing Revenue and Market Share by Manufacturer 3.3 Market Concentration Rate 3.3.1 Top 3 Pharmacy Retailing Manufacturer Market Share 3.3.2 Top 6 Pharmacy Retailing Manufacturer Market Share 3.4 Market Competition Trend 4 Global Pharmacy Retailing Market Analysis by Regions 4.1 Global Pharmacy Retailing Sales, Revenue and Market Share by Regions 4.1.1 Global Pharmacy Retailing Sales by Regions (2012-2017) 4.1.2 Global Pharmacy Retailing Revenue by Regions (2012-2017) 4.2 North America Pharmacy Retailing Sales and Growth (2012-2017) 4.3 Europe Pharmacy Retailing Sales and Growth (2012-2017) 4.4 Asia-Pacific Pharmacy Retailing Sales and Growth (2012-2017) 4.5 South America Pharmacy Retailing Sales and Growth (2012-2017) 4.6 Middle East and Africa Pharmacy Retailing Sales and Growth (2012-2017) 5 North America Pharmacy Retailing by Countries 5.1 North America Pharmacy Retailing Sales, Revenue and Market Share by Countries 5.1.1 North America Pharmacy Retailing Sales by Countries (2012-2017) 5.1.2 North America Pharmacy Retailing Revenue by Countries (2012-2017) 5.2 USA Pharmacy Retailing Sales and Growth (2012-2017) 5.3 Canada Pharmacy Retailing Sales and Growth (2012-2017) 5.4 Mexico Pharmacy Retailing Sales and Growth (2012-2017) For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | February 16, 2017
Site: www.businesswire.com

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global personalized gifts market to grow at a CAGR of more than 9% during the forecast period, according to their latest report. The research study by Technavio on the global personalized gifts market for 2017-2021 provides detailed industry analysis based on skill and technology (hand decoration, embroidery, engraving, printing, and carving), product (photo and non-photo personalized gifts), retail format (in-store and online), and geography (the Americas, Europe, APAC, and MEA). Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more. Technavio analysts highlight the following three key factors that are contributing to the growth of the global personalized gifts market: “The gifting culture is evolving with an increasing number of occasions when gifts are exchanged. Consumers customize gifts through personalization, configuration, or on-demand printing to add value and make their gifts unique,” says Poonam Saini, one of the lead analysts at Technavio for retail goods and services research. Seasonal decorations, such as decorative cups, plates, and napkins, account for a major portion of the total revenue generated in the market. Also, the growing home and wall décor market have also been aiding in the expansion of the growth opportunities for personalized gifts. The demand for these gifts usually experiences a surge during holidays like Christmas, Halloween, Easter, and Hanukkah. Product innovation is a requisite for this market to generate consumer interest and as an extension, its sales. A notable example is Hallmark's recent launch of Hollywood-inspired decorative ornaments based on the popular characters from popular movies, which created a lot of revenue for the market. Currently, eco-friendly gifts and novelty items are garnering significant consumer interest, particularly in children’s toys. Also, to retain consumer loyalty and increase sales, manufacturers are streamlining design and building more efficient ordering processes, enhancing customization capabilities, and brainstorming new ideas. “Retail participation across various distribution channels is an important factor that determines the growth of the global personalized gifts market. Even in the digital age, a high percentage of consumers prefer buying goods from brick-and-mortar stores, due to the personalized nature of these products,” says Poonam. Mass merchandisers, such as Walmart and Target, and pharmacy chains such as CVS Pharmacy and Rite Aid have equipped their stores with dry minilabs, which can provide on-site photo personalized gifts. Additionally, gaining consumer interest and building a brand image through the social media platform is increasing as it is cost-effective and it usually gets faster responses from a large customer base. Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like cosmetics and toiletry, luggage, and pet supplies. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently. Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies. Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users. If you are interested in more information, please contact our media team at media@technavio.com.


SAN DIEGO, April 27, 2016 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the first quarter ended March 31, 2016. __________________________ (1) A reconciliation of GAAP net income to Funds From Operations (FFO) is provided at the end of this press release. Stuart A. Tanz, President and Chief Executive Officer of Retail Opportunity Investments Corp. stated, "As 2016 gets fully underway, we are executing our business plan seamlessly across all disciplines. Year-to-date, we have secured $155.2 million of grocery-anchored shopping center acquisitions. Additionally, we continue to post strong property operating results, including achieving a portfolio lease rate above 97% and a 7.6% increase in same-center cash NOI.” Tanz further stated, “With our strong start to the year, we are excited about the prospects of 2016 shaping up to be another solid year of growth and performance for the company.” For the three months ended March 31, 2016, GAAP net income applicable to common shareholders was $8.9 million, or $0.8 per diluted share, as compared to GAAP net income of $4.4 million, or $0.04 per diluted share for the three months ended March 31, 2015. FFO for the first quarter of 2016 was $29.9 million, or $0.27 per diluted share, as compared to $22.0 million in FFO, or $0.23 per diluted share for the first quarter of 2015, representing a 17.4% increase on a per diluted share basis. ROIC reports FFO as a supplemental performance measure in accordance with the definition set forth by the National Association of Real Estate Investment Trusts. A reconciliation of GAAP net income to FFO is provided at the end of this press release. At March 31, 2016, ROIC had a total market capitalization of approximately $3.3 billion with approximately $1.0 billion of principal debt outstanding, equating to a 31.8% debt-to-total market capitalization ratio. ROIC’s debt outstanding was comprised of $79.4 million of mortgage debt and $954.8 million of unsecured debt, with $169.5 million in principal outstanding on its unsecured credit facility. For the first quarter of 2016, ROIC’s interest coverage was 4.2 times and 93.8% of its portfolio was unencumbered (based on gross leasable area) at March 31, 2016. Year-to-date in 2016, ROIC has committed a total of $155.2 million in grocery-anchored shopping center acquisitions. In March 2016, ROIC acquired the following two-property portfolio for $64.0 million. ROIC funded the acquisition in part with issuance of $46.1 million of ROIC common equity in the form of operating partnership units, based on a value of $18.85 per unit. Magnolia Shopping Center is approximately 116,000 square feet and is anchored by Kroger (Ralph’s) Supermarket. The property is located in Santa Barbara, California and is currently 97.7% leased. Casitas Plaza Shopping Center is approximately 97,000 square feet and is anchored by Albertson’s Supermarket and CVS Pharmacy. The property is located in Carpinteria, California, within Santa Barbara County, and is currently 100% leased. Additionally, ROIC currently has binding contracts to acquire two grocery-anchored shopping centers, in separate transactions, totaling $91.2 million. ROIC has a binding contract to acquire Bouquet Center for $59.0 million. The shopping center is approximately 149,000 square feet and is anchored by Safeway (Vons) Supermarket, CVS Pharmacy and Ross Dress For Less. The property is located in Santa Clarita, California, within the Los Angeles metropolitan area, and is currently 95.0% leased. ROIC has a binding contract to acquire Bridle Trails Shopping Center for $32.2 million. The shopping center is approximately 106,000 square feet and is anchored by Red Apple (Unified) Supermarket and Bartell Drugs, a Seattle-based regional pharmacy. The property is located in Kirkland, Washington, within the Seattle metropolitan area, and is currently 97.0% leased. At March 31, 2016, ROIC’s portfolio was 97.2% leased. For the first quarter of 2016, same-center net operating income (NOI) was $31.4 million, as compared to $29.2 million in same-center NOI for the first quarter of 2015, representing a 7.6% increase. Same-center NOI includes all of the properties owned by ROIC as of January 1, 2015, totaling 61 shopping centers. ROIC reports same-center NOI on a cash basis. A reconciliation of GAAP operating income to same-center NOI is provided at the end of this press release. During the first quarter of 2016, ROIC executed 101 leases, totaling 297,963 square feet, achieving a 12.7% increase in same-space comparative base rent, including 32 new leases, totaling 111,869 square feet, achieving a 15.4% increase in same-space comparative base rent, and 69 renewed leases, totaling 186,094 square feet, achieving an 11.8% increase in base rent. ROIC reports same-space comparative base rent on a cash basis. On March 30, 2016, ROIC distributed an $0.18 per share cash dividend, representing a 5.9% increase as compared to ROIC’s previous dividend. On April 27, 2016, ROIC’s board of directors declared a cash dividend of $0.18 per share, payable on June 29, 2016 to stockholders of record on June 15, 2016. ROIC currently estimates that FFO for the full year 2016 will be within the range of $1.02 to $1.06 per diluted share, and net income to be within the range of $0.33 to $0.34 per diluted share. The following table provides a reconciliation of GAAP net income to FFO. ROIC’s estimates are based on numerous underlying assumptions. ROIC’s management will discuss the company’s guidance and underlying assumptions on its April 28, 2016 conference call. ROIC’s guidance is a forward-looking statement and is subject to risks and other factors described elsewhere in this press release. ROIC will conduct a conference call and audio webcast to discuss its quarterly results on Thursday, April 28, 2016 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time. Those interested in participating in the conference call should dial (877) 312-8783 (domestic), or (408) 940-3874 (international) at least ten minutes prior to the scheduled start of the call. When prompted, provide the Conference ID: 68643666. A live webcast will also be available in listen-only mode at http://www.roireit.net. The conference call will be recorded and available for replay beginning at 1:00 p.m. Eastern Time on April 28, 2016 and will be available until 11:59 p.m. Eastern Time on May 5, 2016. To access the conference call recording, dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and use the Conference ID: 68643666. The conference call will also be archived on http://www.roireit.net for approximately 90 days. Retail Opportunity Investments Corp. (NASDAQ:ROIC), is a fully-integrated, self-managed real estate investment trust (REIT) that specializes in the acquisition, ownership and management of grocery-anchored shopping centers located in densely-populated, metropolitan markets across the West Coast. As of March 31, 2016, ROIC owned 75 shopping centers encompassing approximately 8.8 million square feet. ROIC is the largest publicly-traded, grocery-anchored shopping center REIT focused exclusively on the West Coast. ROIC is a member of the S&P SmallCap 600 Index and has investment-grade corporate debt ratings from Moody's Investor Services and Standard & Poor's. Additional information is available at: www.roireit.net. When used herein, the words "believes," "anticipates," "projects," "should," "estimates," "expects," “guidance” and similar expressions are intended to identify forward-looking statements with the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and in Section 21F of the Securities and Exchange Act of 1934, as amended. Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results of ROIC to differ materially from future results expressed or implied by such forward-looking statements. Information regarding such risks and factors is described in ROIC's filings with the SEC, including its most recent Annual Report on Form 10-K, which is available at: www.roireit.net. RETAIL OPPORTUNITY INVESTMENTS CORP. Consolidated Statements of Operations  (In thousands, except per share data) SAME-CENTER CASH NET OPERATING INCOME ANALYSIS (Unaudited) (In thousands, except number of shopping centers and percentages) (1) Includes straight-line rents, amortization of above and below-market lease intangibles, anchor lease termination fees, net of contractual amounts, and expense and recovery adjustments related to prior periods. Funds from operations (“FFO”), is a widely‑recognized non‑GAAP financial measure for REITs that the Company believes when considered with financial statements presented in accordance with GAAP, provides additional and useful means to assess its financial performance. FFO is frequently used by securities analysts, investors and other interested parties to evaluate the performance of REITs, most of which present FFO along with net income as calculated in accordance with GAAP. The Company computes FFO in accordance with the “White Paper” on FFO published by the National Association of Real Estate Investment Trusts (“NAREIT”), which defines FFO as net income attributable to common stockholders (determined in accordance with GAAP) excluding gains or losses from debt restructuring, sales of depreciable property and impairments, plus real estate related depreciation and amortization, and after adjustments for partnerships and unconsolidated joint ventures. The Company uses cash net operating income (“NOI”) internally to evaluate and compare the operating performance of the Company’s properties. The Company believes cash NOI provides useful information to investors regarding the Company’s financial condition and results of operations because it reflects only those income and expense items that are incurred at the property level, and when compared across periods, can be used to determine trends in earnings of the Company’s properties as this measure is not affected by the non-cash revenue and expense recognition items, the cost of the Company’s funding, the impact of depreciation and amortization expenses, gains or losses from the acquisition and sale of operating real estate assets, general and administrative expenses or other gains and losses that relate to the Company’s ownership of properties. The Company believes the exclusion of these items from operating income is useful because the resulting measure captures the actual revenue generated and actual expenses incurred in operating the Company’s properties as well as trends in occupancy rates, rental rates and operating costs. Cash NOI is a measure of the operating performance of the Company’s properties but does not measure the Company’s performance as a whole and is therefore not a substitute for net income or operating income as computed in accordance with GAAP. The Company defines cash NOI as operating revenues (base rent and recoveries from tenants), less property and related expenses (property operating expenses and property taxes), adjusted for non-cash revenue and operating expense items such as straight-line rent and amortization of lease intangibles, debt-related expenses and other adjustments. Cash NOI also excludes general and administrative expenses, depreciation and amortization, acquisition transaction costs, other expense, interest expense, gains and losses from property acquisitions and dispositions, extraordinary items, tenant improvements and leasing commissions.  Other REITs may use different methodologies for calculating cash NOI, and accordingly, the Company’s cash NOI may not be comparable to other REITs.


SAN DIEGO, April 27, 2016 (GLOBE NEWSWIRE) -- Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today financial and operating results for the first quarter ended March 31, 2016. __________________________ (1) A reconciliation of GAAP net income to Funds From Operations (FFO) is provided at the end of this press release. Stuart A. Tanz, President and Chief Executive Officer of Retail Opportunity Investments Corp. stated, "As 2016 gets fully underway, we are executing our business plan seamlessly across all disciplines. Year-to-date, we have secured $155.2 million of grocery-anchored shopping center acquisitions. Additionally, we continue to post strong property operating results, including achieving a portfolio lease rate above 97% and a 7.6% increase in same-center cash NOI.” Tanz further stated, “With our strong start to the year, we are excited about the prospects of 2016 shaping up to be another solid year of growth and performance for the company.” For the three months ended March 31, 2016, GAAP net income applicable to common shareholders was $8.9 million, or $0.08 per diluted share, as compared to GAAP net income of $4.4 million, or $0.04 per diluted share for the three months ended March 31, 2015. FFO for the first quarter of 2016 was $29.9 million, or $0.27 per diluted share, as compared to $22.0 million in FFO, or $0.23 per diluted share for the first quarter of 2015, representing a 17.4% increase on a per diluted share basis. ROIC reports FFO as a supplemental performance measure in accordance with the definition set forth by the National Association of Real Estate Investment Trusts. A reconciliation of GAAP net income to FFO is provided at the end of this press release. At March 31, 2016, ROIC had a total market capitalization of approximately $3.3 billion with approximately $1.0 billion of principal debt outstanding, equating to a 31.8% debt-to-total market capitalization ratio. ROIC’s debt outstanding was comprised of $79.4 million of mortgage debt and $954.8 million of unsecured debt, with $169.5 million in principal outstanding on its unsecured credit facility. For the first quarter of 2016, ROIC’s interest coverage was 4.2 times and 93.8% of its portfolio was unencumbered (based on gross leasable area) at March 31, 2016. Year-to-date in 2016, ROIC has committed a total of $155.2 million in grocery-anchored shopping center acquisitions. In March 2016, ROIC acquired the following two-property portfolio for $64.0 million. ROIC funded the acquisition in part with issuance of $46.1 million of ROIC common equity in the form of operating partnership units, based on a value of $18.85 per unit. Magnolia Shopping Center is approximately 116,000 square feet and is anchored by Kroger (Ralph’s) Supermarket. The property is located in Santa Barbara, California and is currently 97.7% leased. Casitas Plaza Shopping Center is approximately 97,000 square feet and is anchored by Albertson’s Supermarket and CVS Pharmacy. The property is located in Carpinteria, California, within Santa Barbara County, and is currently 100% leased. Additionally, ROIC currently has binding contracts to acquire two grocery-anchored shopping centers, in separate transactions, totaling $91.2 million. ROIC has a binding contract to acquire Bouquet Center for $59.0 million. The shopping center is approximately 149,000 square feet and is anchored by Safeway (Vons) Supermarket, CVS Pharmacy and Ross Dress For Less. The property is located in Santa Clarita, California, within the Los Angeles metropolitan area, and is currently 95.0% leased. ROIC has a binding contract to acquire Bridle Trails Shopping Center for $32.2 million. The shopping center is approximately 106,000 square feet and is anchored by Red Apple (Unified) Supermarket and Bartell Drugs, a Seattle-based regional pharmacy. The property is located in Kirkland, Washington, within the Seattle metropolitan area, and is currently 97.0% leased. At March 31, 2016, ROIC’s portfolio was 97.2% leased. For the first quarter of 2016, same-center net operating income (NOI) was $31.4 million, as compared to $29.2 million in same-center NOI for the first quarter of 2015, representing a 7.6% increase. Same-center NOI includes all of the properties owned by ROIC as of January 1, 2015, totaling 61 shopping centers. ROIC reports same-center NOI on a cash basis. A reconciliation of GAAP operating income to same-center NOI is provided at the end of this press release. During the first quarter of 2016, ROIC executed 101 leases, totaling 297,963 square feet, achieving a 12.7% increase in same-space comparative base rent, including 32 new leases, totaling 111,869 square feet, achieving a 15.4% increase in same-space comparative base rent, and 69 renewed leases, totaling 186,094 square feet, achieving an 11.8% increase in base rent. ROIC reports same-space comparative base rent on a cash basis. On March 30, 2016, ROIC distributed an $0.18 per share cash dividend, representing a 5.9% increase as compared to ROIC’s previous dividend. On April 27, 2016, ROIC’s board of directors declared a cash dividend of $0.18 per share, payable on June 29, 2016 to stockholders of record on June 15, 2016. ROIC currently estimates that FFO for the full year 2016 will be within the range of $1.02 to $1.06 per diluted share, and net income to be within the range of $0.33 to $0.34 per diluted share. The following table provides a reconciliation of GAAP net income to FFO. ROIC’s estimates are based on numerous underlying assumptions. ROIC’s management will discuss the company’s guidance and underlying assumptions on its April 28, 2016 conference call. ROIC’s guidance is a forward-looking statement and is subject to risks and other factors described elsewhere in this press release. ROIC will conduct a conference call and audio webcast to discuss its quarterly results on Thursday, April 28, 2016 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time. Those interested in participating in the conference call should dial (877) 312-8783 (domestic), or (408) 940-3874 (international) at least ten minutes prior to the scheduled start of the call. When prompted, provide the Conference ID: 68643666. A live webcast will also be available in listen-only mode at http://www.roireit.net. The conference call will be recorded and available for replay beginning at 1:00 p.m. Eastern Time on April 28, 2016 and will be available until 11:59 p.m. Eastern Time on May 5, 2016. To access the conference call recording, dial (855) 859-2056 (domestic) or (404) 537-3406 (international) and use the Conference ID: 68643666. The conference call will also be archived on http://www.roireit.net for approximately 90 days. Retail Opportunity Investments Corp. (NASDAQ:ROIC), is a fully-integrated, self-managed real estate investment trust (REIT) that specializes in the acquisition, ownership and management of grocery-anchored shopping centers located in densely-populated, metropolitan markets across the West Coast. As of March 31, 2016, ROIC owned 75 shopping centers encompassing approximately 8.8 million square feet. ROIC is the largest publicly-traded, grocery-anchored shopping center REIT focused exclusively on the West Coast. ROIC is a member of the S&P SmallCap 600 Index and has investment-grade corporate debt ratings from Moody's Investor Services and Standard & Poor's. Additional information is available at: www.roireit.net. When used herein, the words "believes," "anticipates," "projects," "should," "estimates," "expects," “guidance” and similar expressions are intended to identify forward-looking statements with the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and in Section 21F of the Securities and Exchange Act of 1934, as amended. Certain statements contained herein may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results of ROIC to differ materially from future results expressed or implied by such forward-looking statements. Information regarding such risks and factors is described in ROIC's filings with the SEC, including its most recent Annual Report on Form 10-K, which is available at: www.roireit.net. RETAIL OPPORTUNITY INVESTMENTS CORP. Consolidated Statements of Operations  (In thousands, except per share data) SAME-CENTER CASH NET OPERATING INCOME ANALYSIS (Unaudited) (In thousands, except number of shopping centers and percentages) (1) Includes straight-line rents, amortization of above and below-market lease intangibles, anchor lease termination fees, net of contractual amounts, and expense and recovery adjustments related to prior periods. Funds from operations (“FFO”), is a widely‑recognized non‑GAAP financial measure for REITs that the Company believes when considered with financial statements presented in accordance with GAAP, provides additional and useful means to assess its financial performance. FFO is frequently used by securities analysts, investors and other interested parties to evaluate the performance of REITs, most of which present FFO along with net income as calculated in accordance with GAAP. The Company computes FFO in accordance with the “White Paper” on FFO published by the National Association of Real Estate Investment Trusts (“NAREIT”), which defines FFO as net income attributable to common stockholders (determined in accordance with GAAP) excluding gains or losses from debt restructuring, sales of depreciable property and impairments, plus real estate related depreciation and amortization, and after adjustments for partnerships and unconsolidated joint ventures. The Company uses cash net operating income (“NOI”) internally to evaluate and compare the operating performance of the Company’s properties. The Company believes cash NOI provides useful information to investors regarding the Company’s financial condition and results of operations because it reflects only those income and expense items that are incurred at the property level, and when compared across periods, can be used to determine trends in earnings of the Company’s properties as this measure is not affected by the non-cash revenue and expense recognition items, the cost of the Company’s funding, the impact of depreciation and amortization expenses, gains or losses from the acquisition and sale of operating real estate assets, general and administrative expenses or other gains and losses that relate to the Company’s ownership of properties. The Company believes the exclusion of these items from operating income is useful because the resulting measure captures the actual revenue generated and actual expenses incurred in operating the Company’s properties as well as trends in occupancy rates, rental rates and operating costs. Cash NOI is a measure of the operating performance of the Company’s properties but does not measure the Company’s performance as a whole and is therefore not a substitute for net income or operating income as computed in accordance with GAAP. The Company defines cash NOI as operating revenues (base rent and recoveries from tenants), less property and related expenses (property operating expenses and property taxes), adjusted for non-cash revenue and operating expense items such as straight-line rent and amortization of lease intangibles, debt-related expenses and other adjustments. Cash NOI also excludes general and administrative expenses, depreciation and amortization, acquisition transaction costs, other expense, interest expense, gains and losses from property acquisitions and dispositions, extraordinary items, tenant improvements and leasing commissions.  Other REITs may use different methodologies for calculating cash NOI, and accordingly, the Company’s cash NOI may not be comparable to other REITs.


News Article | January 12, 2017
Site: www.techtimes.com

CVS has announced that it would sell a generic version of an EpiPen competitor at a far lower price than that of the controversial EpiPen. The nation's largest drugstore chain announced on Thursday that it would sell the generic version of Impax Laboratories' Adrenaclick treatment for life-threatening allergic reactions. CVS' move is apparently a bid to offer consumers a more affordable but safe alternative to Epipen amid the skyrocketing cost of Mylan's controversial epinephrine autoinjector and following Trump lambasting drugmakers on Wednesday, Jan. 11, for the hikes in drug prices. Epipen delivers epinephrine, a synthetic adrenaline that can counter the potentially deadly effects of severe allergic reactions. People suffering from food allergies rely on Epipens for life-saving treatment, but the price of the autoinjector has swollen over the past years, making it too prohibitive for some families. In 2009, a two-pack Epipens costs only around $100, but the price has since skyrocketed to more than $600. In an effort to save, some Americans resorted to using do-it-your-own alternatives that, when used incorrectly, can have serious and even deadly consequences. Mylan, in an effort to appease the public's resentment over the pricey cost of its autoinjector, said that it would start selling a generic version of the EpiPen for $300 per two-pack, which is more than 50 percent cheaper than the price of the regular Epipen. Adrenaclick is a lesser-known epinephrine delivery product that was green-lighted by the Food and Drug Administration in 2003. Regulators do not consider it as an exact copy of the EpiPen, but it contains the same active ingredient found in Mylan's autoinjector. Adrenaclick administers the drug through a slightly different injection. CVS said that it would offer the authorized generic of Adrenaclick two-pack at $109.99 for insured and cash-paying patients without insurance, which means that it would be offered at about 80 percent of the current EpiPen price. The price of generic Adrenaclick remains cheaper even when compared with that of the generic version of EpiPen. Additional cost reductions for the generic Adrenaclick can also be availed by qualified patients who use the coupon programs offered through Impax that would provide a benefit of $100 per pack. "We are thrilled to work with CVS Health to increase access to our low-cost generic Adrenaclick epinephrine auto-injector," said Douglas Boothe, president of Generics Division at Impax Laboratories. "Families need and deserve an affordable option to treat severe allergies." CVS Pharmacy president Helena Foulkes said that Medicaid and Medicare plan members won't qualify for the $100 coupon, but CVS pharmacists will work with customers to determine the cheapest route to acquire the treatment. Foulkes said that the company responded after hearing streams of concern from customers complaining about the price increases of EpiPen. "Our focus has always been on finding solutions for patients first and foremost," Foulkes said. "The best thing that can happen to keep drug prices low is to have a lot of competition in the marketplace." © 2017 Tech Times, All rights reserved. Do not reproduce without permission.


News Article | December 14, 2016
Site: www.prnewswire.com

KANSAS CITY, Mo., Dec. 14, 2016 /PRNewswire-USNewswire/ -- The Kansas City Area Development Council announced today that CVS Pharmacy, America's leading retail pharmacy, will build a 762,000-sq.-ft. distribution center at KC's Skyport Industrial Park. The new distribution center is...


COLORADO SPRINGS, CO--(Marketwired - November 17, 2016) - Global Market Development Center's (GMDC) latest Health & Wellness Best Practices whitepaper, "Retail Partnering to Serve the Beauty Shopper," explores how the Unilever and CVS Pharmacy companies connected beauty care, health care and self-care in the skin care aisle -- reinforcing the rapidly changing trends in the marketplace. Engaged consumers, strong sales and distinguished recognition were the results of the pioneering campaign. In 2014, having realized their goals and values were aligned, Unilever and CVS Pharmacy partnered and created a platform that combined their skin care brands and skin health consumer education. The outcome was Love Your Skin, a campaign that consisted of special offers available exclusively through CVS Pharmacy for different SKUs of three Unilever brands - Dove, Vaseline and Simple. The combination of product offers with non-branded content on skin care and health provided by Dr. Mona Gohara -- a well-known, highly respected, board-certified dermatologist -- made the campaign the first of its kind. At the time, no major manufacturers were providing comprehensive skin health information to consumers. Both companies recognized the opportunity that was set before them - according to the GMDC/Nielsen HBW Hierarchy, beauty sales across all outlets totaled $16.52 billion, an increase of 1.5 percent year-over-year while it's projected that the beauty industry will grow through 2020 at an annual rate of two to three percent. "The skin care category is an important business for both food and drug retailers, playing a key role in beauty care and over-the-counter health care," said GMDC's President/CEO Patrick Spear. "At the same time, growing numbers of consumers seek information about the ingredients and efficacy of the personal care products they use. Together, those trends encouraged a new kind of retailer-suppler partnership, one that demanded innovative departures from tried-and-true." "For a manufacturer to take on the role of content provider and invest dollars in creating brand-agnostic health information, and then making it available to a retailer who provides that content to the shopper is very exciting, I think," said Andrea McGovern Galo, the manager of skin shopper marketing, drug channel at Unilever. The fastest growing segments driving the beauty industry are the Millennial and Generation Xers. Nielsen has found that Millennial households spent $461 million on beauty products in a 12 month period, while Generation X households spent $337 million in the same period. In addition, Hispanics are also playing a larger role in the beauty industry, accounting for about 16 percent of total hair care sales, 14 percent of fragrance sales and 13 percent of cosmetics sales. According to Cory Fraehsdorf, shopper marketing, drug channel at Unilever, an important factor underlying the success of Love Your Skin was the tremendous extent of customer research, which involved Kantar, a market research firm that surveyed CVS Pharmacy skin care shoppers about their attitudes toward their skin. "What emerged from the survey is that there are two distinct groups who shop skin care at CVS Pharmacy," said McGovern Galo. "One is very involved in the category, uses very advanced regimens and is willing to try the latest products, including high-end items. At the other end of the spectrum is a group who uses a limited regimen and much more basic products." These insights, along with data from the CVS Pharmacy ExtraCare loyalty program, provided Unilever with consumer-based information used to create personalized, relevant offers to CVS Pharmacy skin care customers. From the CVS Pharmacy perspective, the program's success and the experience that led to it yielded additional wins that went beyond the numbers. "It required a deeper understanding of our customers' needs, an appreciation of our individual company strengths, and different ways of thinking and working together in both of our organizations to achieve our shared ambitious goals," said Maly Bernstein, a divisional merchandise manager at CVS Pharmacy. Global Market Development Center (GMDC) energizes members and the marketplace by advancing a culture of Connect-Collaborate-Create-Commerce. As the leading GM and HBW trade association, GMDC is dedicated to serving its ecosystem of more than 600 General Merchandise and Health Beauty Wellness retailers, wholesalers, suppliers and service/solution member companies by enabling consumer-facing innovation and retail reimagined. GMDC's combined member volume represents more than 125,000 retail outlets and more than $500 billion in sales. To learn more, visit gmdc.org.


WOONSOCKET, R.I., Feb. 22, 2017 /PRNewswire/ -- CVS Pharmacy is the first national retail pharmacy chain to announce the removal of partially hydrogenated oils (PHO), the primary source of artificial trans fats in processed foods, from all its exclusive store brands food products. The...

Loading CVS Pharmacy collaborators
Loading CVS Pharmacy collaborators